"A new wave of startups is racing to commercialize both implantable and noninvasive BCIs, backed by stronger policy support, expanding clinical trials, and growing investor interest. So says Phoenix Peng, who has founded not one, but two BCI startups. He's a co-founder of NeuroXess, maker of BCI implants, as well as founder and CEO of noninvasive ultrasound BCI startup Gestala."
""I have always maintained that neuroscience and AI are two sides of the same coin. They are destined for deep integration, realizing direct high-bandwidth connections between the human brain and AI. BCI will serve as the ultimate bridge between carbon-based and silicon-based intelligence. While this may sound distant, it represents an unimaginably vast market in the future," Peng said."
China's brain-computer interface (BCI) industry is moving from research into commercialization across both implantable and noninvasive devices. Startups are accelerating product development amid stronger policy backing, expanding clinical trials, and rising investor interest. Provinces including Sichuan, Hubei, and Zhejiang have set medical service prices for BCI, aiding inclusion in the national medical insurance system. A national roadmap issued in August 2025 targets technical milestones by 2027 and a full supply chain by 2030, aiming to build globally competitive firms. Near-term market growth will concentrate in healthcare, with potential long-term expansion into human augmentation and AI integration.
Read at TechCrunch
Unable to calculate read time
Collection
[
|
...
]